Structural Barriers and the Future of AI in Global Health: Lessons From Eradicable Diseases

Despite the unprecedented scientific and technological capacity to eradicate and reduce diseases of poverty, a substantial burden of preventable mortality and morbidity persists in low- and middle-income countries. A new study published by the California Institute of Behavioral Neurosciences & Psychology highlights the critical role of structural barriers in hindering the implementation of proven, cost-effective interventions. The research emphasizes that political will, rather than technological innovation, is the decisive determinant of progress in achieving equitable health outcomes.

Key Takeaways:

• The study identifies two primary categories of diseases that can be eliminated or significantly reduced using existing interventions: eradicable diseases such as poliomyelitis, measles, and malaria, and highly reducible conditions such as cervical cancer and maternal mortality.
• Despite the availability of proven, cost-effective interventions, their implementation is persistently hindered by weak health systems, inequitable funding, fragmented governance, and sociocultural barriers.
• The estimated costs of eradication are modest compared with global expenditures in other sectors, underscoring the need for political will to achieve equitable health outcomes.
• The study calls for reframing disease eradication as a political and moral imperative, prioritizing governance and system capacity alongside technological innovation to achieve equitable health outcomes.
• The underutilization of current tools is the strongest predictor of how future innovations, including AI, will be deployed, highlighting the need for structural reforms to strengthen health systems and ensure equitable resource distribution.
• The study emphasizes the importance of accountability in ensuring that innovations, including AI, are used to improve health outcomes rather than perpetuating existing inequities.

Statistics:

• The study estimates that the costs of eradicating diseases such as polio, measles, and malaria are modest, at around $1.4 billion per year for the next decade.
• According to the World Health Organization (World Health Organization), an estimated 19.3 million people died from catastrophic health conditions in 2019, with the majority being preventable.
• The study highlights the persistent inequities in health outcomes, with 85% of the global disease burden concentrated in just 18 countries.

Sources:

• NewsRx. New Science Study Results Reported from California Institute of Behavioral Neurosciences & Psychology (Structural Barriers and the Future of AI in Global Health: Lessons From Eradicable Diseases). Science Letter. October 31, 2025; p 75.
• Cureus. Structural Barriers and the Future of AI in Global Health: Lessons From Eradicable Diseases. 2025;17(9).
• Ryan R. Haddad, Clinical Research, California Institute of Behavioral Neurosciences & Psychology, Fairfield, United States.